Mangoceuticals Inc. Terminates Business Combination with Nuclea Energy
Acquiring Company
MANGOCEUTICALS
Acquired Company
Nuclea Energy
Dallas
CalgaryOtherBiotechnologyHealth CareDietary SupplementsNutritionManufacturingEnergyRenewable EnergyDescription
On August 19, 2026, Mangoceuticals, Inc. and Nuclea Energy Inc. mutually agreed to terminate their Business Combination Agreement. The agreement was initially set to outline a strategic business combination transaction. The termination was in accordance with the BCA conditions that required finalizing financing arrangements.
Don't miss MANGOCEUTICALS's next move
Get an email the moment MANGOCEUTICALS makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Nuclea Energy?
Nuclea Energy was acquired by MANGOCEUTICALS, based in Dallas. The deal was reported on August 21, 2026. MANGOCEUTICALS is publicly traded (MGRX) and operates in Other.
When did MANGOCEUTICALS acquire Nuclea Energy?
MANGOCEUTICALS's acquisition of Nuclea Energy was reported on August 21, 2026. On August 19, 2026, Mangoceuticals, Inc. and Nuclea Energy Inc. mutually agreed to terminate their Business Combination Agreement. The agreement was initially set to outline a strategic business combination transaction. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Nuclea Energy do?
Nuclea Energy Inc. is a Canadian advanced-nuclear technology company developing micro modular reactor systems that deliver clean, safe, and continuous power to industries and communities worldwide. It is privately held, operating in Manufacturing, and is based in Calgary.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.